FDA 483 - Hospira, Inc. - August 04, 2011
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Hospira, Inc. in Rocky Mount, NC, a sterile pharmaceutical manufacturer, was cited for significant deficiencies in its quality control and laboratory operations. The inspection revealed a failure to thoroughly investigate out-of-specification results and batch failures, leading to the release of non-conforming product lots. Additionally, the firm lacked scientifically sound test procedures, including inadequate method transfers and verifications for various drug products.
ID · 985730f5-cef4-479b-8ac8-0e7241142062